ATAI Life Sciences BV (ATAI) Financials

$7.39

$0.05 (0.68%)

As on 04-Sep-2026 19:21EDT

Market cap

$2,741 Mln

Revenue (TTM)

$4 Mln

P/E Ratio

--

P/B Ratio

15.5

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-102.68	-82.44	-84.12	-104.47	-63.25
Cash Flow from Investing Activities	--	-109.13	59.17	-53.30	-86.85	-81.28
Cash from Financing Activities	--	269.48	5.37	-8.36	20.79	409.86
Net Cash Inflow / Outflow	--	--	--	--	-170.53	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-2.91	-2.97	-0.93	-0.25	-0.96	-1.11
Cash EPS ($)	--	-2.97	-0.93	-0.25	-0.96	-1.11
Adjusted Book Value ($)	--	1.00	0.73	1.53	1.64	2.49
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.46	-0.51	-0.53	-0.66	-0.42
Free Cash Flow per Share ($)	--	-0.47	-0.52	-0.53	-0.66	-0.43

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-361.72	-74.06	-14.95	-46.62	-71.31
ROE (%)	-335.53	-390.36	-83.10	-15.97	-47.80	-71.75
ROA (%)	-263.03	-280.91	-65.92	-13.43	-42.35	-63.84
EBIT Margin (%)	-15,198.77	-16,108.76	-47,988.96	-12,809.87	-64,491.42	-874.72
Net Margin (%)	-14,938.37	-16,142.02	-48,463.96	-12,810.19	2,470.57	-823.56
Cash Profit Margin (%)	-0.02	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	93.72	12.28	-0.02	0.35	-0.99	0.02
EBIT Growth (%)	-530.01	-345.64	-267.47	73.23	15.69	-71.11
Net Profit Growth (%)	-460.04	-342.19	-271.09	73.60	9.19	1.20
EPS Growth (%)	-316.60	-2.19	-2.68	0.74	0.14	0.00
Book Value Growth (%)	-33.14	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-1.38	-1.43	-5.57	-2.77	-6.87
Price / Book Value	15.46	4.09	1.83	0.92	1.62	3.06
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.27	-0.99	-1.19	-1.60	-1.10	-4.44
Close Price ($)	5.27	4.09	1.33	1.41	2.66	7.63
High Price ($)	6.75	6.75	2.85	2.76	7.98	22.91
Low Price ($)	2.36	1.15	1.03	1.03	2.34	6.60
Market Cap ($ Cr)	2,740.69	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.21	0.08	0.06	0.00
Short term debt to equity ratio	0.02	0.00	0.08	0.00	0.00	--
Current Ratio	8.58	11.74	3.21	9.22	14.43	17.92
Quick Ratio	8.58	--	--	10.47	14.71	--
Interest Coverage	-334,090.00	-566.86	-47.31	-15.14	-162.80	-2.66

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	14.46	352.82	437.66	718.79	2,416.74	31.01
Asset Turnover	0.02	0.02	0.00	0.00	0.00	0.08
Receivable days	--	704.55	2,137.54	4,587.73	9,366.39	68.21
Inventory Days	--	--	-19,304.97	-17,536.01	-12,242.40	3,551.47
Payable days	--	1,357.42	2,781.85	4,000.58	9,134.51	35,308.80
Cash Conversion Cycle	--	--	-19,949.27	-16,948.86	-12,010.52	-31,689.12

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.